ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,842.63
1.12%
US Tech 100
20,080.40
0.00%
다우존스 지수
43,006.59
1.14%
Bitcoin
91,281.21
0.72%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Bicara Therapeutics Inc (BCAX) 시세

Bicara Therapeutics Inc

Bicara Therapeutics Inc (BCAX)

NASDAQ
14.88
0.00
(0.00%)
마감 06 3월 6:00AM
15분 지연
0.00
0.00
(0.00%)
시간외 거래: -
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
14.88
매수가
13.16
매도가
14.98
거래량
-
0.00 일간 변동폭 0.00
11.10 52주 범위 27.95
market_cap
809.704M
전일 종가
14.88
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
449,993
발행 주식
54,415,619
배당수익률
-
주가수익률
-15.58
주당순이익(EPS)
-0.96
매출
-
순이익
-51.99M

Bicara Therapeutics Inc 정보

Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor... Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. Ficerafusp alfa is initially being developed in head and neck squamous cell carcinoma, or HNSCC, where there remains a significant unmet need. We intend to initiate a pivotal Phase 2/3 trial of ficerafusp alfa in combination with pembrolizumab as a first-line therapy in recurrent/metastatic HNSCC excluding HPV-positive patients with oropharyngeal squamous cell carcinoma late in the fourth quarter of 2024 or early in the first quarter of 2025. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.bicara.com
본부
Wilmington, Delaware, USA
설립됨
-
Bicara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker BCAX. The last closing price for Bicara Therapeutics was US$14.88. Over the last year, Bicara Therapeutics shares have traded in a share price range of US$ 11.10 to US$ 27.95.

Bicara Therapeutics currently has 54,415,619 shares in issue. The market capitalisation of Bicara Therapeutics is US$809.70 million. Bicara Therapeutics has a price to earnings ratio (PE ratio) of -15.58.

BCAX 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
13 1월 2025
BCAX (0.00%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 11월 2024
BCAX (0.00%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
12.5620.779220779212.3214.9311.76528916213.51172886CS
41.047.5144508670513.8414.9311.6434433413.03446568CS
12-4.73-24.120346761919.6120.708711.144999314.86516921CS
26-11.37-43.314285714326.2527.9511.141276618.47209413CS
52-11.37-43.314285714326.2527.9511.141276618.47209413CS
156-11.37-43.314285714326.2527.9511.141276618.47209413CS
260-11.37-43.314285714326.2527.9511.141276618.47209413CS

BCAX - Frequently Asked Questions (FAQ)

What is the current Bicara Therapeutics share price?
The current share price of Bicara Therapeutics is US$ 14.88
How many Bicara Therapeutics shares are in issue?
Bicara Therapeutics has 54,415,619 shares in issue
What is the market cap of Bicara Therapeutics?
The market capitalisation of Bicara Therapeutics is USD 809.7M
What is the 1 year trading range for Bicara Therapeutics share price?
Bicara Therapeutics has traded in the range of US$ 11.10 to US$ 27.95 during the past year
What is the PE ratio of Bicara Therapeutics?
The price to earnings ratio of Bicara Therapeutics is -15.58
What is the reporting currency for Bicara Therapeutics?
Bicara Therapeutics reports financial results in USD
What is the latest annual profit for Bicara Therapeutics?
The latest annual profit of Bicara Therapeutics is USD -51.99M
What is the registered address of Bicara Therapeutics?
The registered address for Bicara Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Bicara Therapeutics website address?
The website address for Bicara Therapeutics is www.bicara.com
Which industry sector does Bicara Therapeutics operate in?
Bicara Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.5761
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.21
(0.00%)
0
AACGATA Creativity Global
US$ 0.8244
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.5761
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.21
(0.00%)
0
AACGATA Creativity Global
US$ 0.8244
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.5761
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.21
(0.00%)
0
AACGATA Creativity Global
US$ 0.8244
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.03
(0.00%)
0

토론

전체 피드 보기
elks elks 4 분 전
Yea 10 cent pass should be a given here. Gvsi
GVSI
elks elks 10 분 전
Give me. 10. GV.
GV
Seminole Red Seminole Red 12 분 전
https://scontent-mia3-3.xx.fbcdn.net/v/t39.30808-6/481480719_987512600144418_2190393473355075201_n.jpg?_nc_cat=110&ccb=1-7&_nc_sid=127cfc&_nc_ohc=EBBGizwR9WgQ7kNvgFgaVah&_nc_oc=AdiGAltt3RReq6HTCuijQmYlSDgZPtmAgDbgsZO-4kppXvDaDLBo7dcCTVBLo8rGcPhz5aLGeXmDPKsdQ0T9ZxGy&_nc_zt=23&_nc_ht=scontent-mia3-3.x
PJ3000 PJ3000 13 분 전
$104m annual sales reported March 2025, and $2m daily sales reported in Sep 2024, ca. 180 days before. At the same time it's 1650% growth, even 1700. Please tell me this is not cherry-picking and not a platform.

https://www.globenewswire.com/news-release/2025/03/03/3035792/0/en/Olived
OLVI
SilkRoad SilkRoad 14 분 전
The longer we go into 2025 with no production update the more it feels like Groundhog Day all over again. Let’s get moving KBLB!
https://investorshub.advfn.com/uimage/uploads/2025/3/6/osefqIMG_4531.jpeg
KBLB
againstallodds againstallodds 18 분 전
No significant short positions uncovered

Paig social promo clowns trying to use that old trick

No uncovered = No short squeeze

From OTC

https://investorshub.advfn.com/uimage/uploads/2025/3/6/rcmnhIMG_0326.jpeg
NBRI
havnagoodtime havnagoodtime 21 분 전
You could request a review, if you want.
HMBL
sam1933 sam1933 24 분 전
Neuron Goes Live on Hedera to Prevent Aerial Disasters
[pre]After a tragic plane-helicopter collision killed 67,
aviation safety is in focus.[/pre]

https://www.altcoinbuzz.io/cryptocurrency-news/neuron-goes-live-on-hedera-to-prevent-aerial-disasters/
HBARUSD
sam1933 sam1933 30 분 전
Hedera: A Fit For All Narratives
https://i.redd.it/phvz36igctce1.jpeg
HBARUSD
Seminole Red Seminole Red 34 분 전
you guys put up some good ones always.
Seminole Red Seminole Red 38 분 전
sure are alot of WD's this week
pgsd pgsd 48 분 전
As the report in your link clearly shows .....NOT

“We are starting to make progress. We now have a few syngenic, clinically relevant mouse models, but we don’t still have the richness of, say, breast or lung cancer, where there are hundreds of relevant models.”

"Mouse
NWBO
Toofuzzy Toofuzzy 54 분 전
With the turmoil in the market I decided to review all my holdings for AIM directed trades.

I sold WPM and because of option selling will have to wait till next January to sell more. Most options have a $75 strike.

I decided to close out trading on EFA. AIM has hardly g
Investor082 Investor082 54 분 전
She will release fluff PRs such as Oncovir partnership and likely news on combo trials but none of that will move the stock, just like Roswell Park announcement. In fact, any PR that does not involve significant non dilutive cash will ultimately result in sell the news scenario. Only news that matte
NWBO
DesktopDR DesktopDR 1 시간 전
Class Action Lawsuits topped 40 Billion again in 2024. If the right media covers this, VPLM's stock price will soar!
https://www.forbes.com/sites/edwardsegal/2025/01/07/class-action-settlements-topped-40-billion-again-in-2024-new-report/
VPLM
HoldEm777 HoldEm777 1 시간 전
That’s a “hundo” each trip up now for a month. That’s a solid tip you think?
https://investorshub.advfn.com/uimage/uploads/2025/3/6/ip[quIMG_7898.png
GTVH
RDY2ROCK RDY2ROCK 1 시간 전
https://www.binance.com/en/square/post/19247288481466
The 2025 NFT Outlook

Even if the market is down, the technology and ideas behind it are still significant, and experts are forecasting that the industry will mature beyond its early excitement.

One potential r
PSRU
Big Momma Big Momma 1 시간 전
If so confident, why so focused on what others are doing?

investorshub.advfn.com/uimage/uploads/2014/11/19/koxivYoda.jpg
HLLK
Toofuzzy Toofuzzy 1 시간 전
Re: options with AIM

I use options three different ways.

1) I sell options equal to the amount I would sell.

If I own 1000 shares I might sell one option at the next trade price ( put or call ). Ideally the option premium takes me to the second trade pric
Toofuzzy Toofuzzy 1 시간 전
Re: options with AIM

I use options three different ways.

1) I sell options equal to the amount I would sell.

If I own 1000 shares I might sell one option at the next trade price ( put or call ). Ideally the option premium takes me to the second trade pric
RDY2ROCK RDY2ROCK 1 시간 전
No BELR RS on the Horizon. Last split was 1:100 OCT 2017.
https://otce.finra.org/otce/dailyList?viewType=Dividends%2FDistributions%2FSplits
Which also shows on the OTC site:
https://www.otcmarkets.com/stock/BELR/security
AS = 5B & OS = 421,952,476 on 5 MAR 2025
BELR
NotSure2 NotSure2 1 시간 전
What happen to your "confirm info" that was ckearly wrong? You are just going to say "this week" everyweek?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175849282

Fireman/Smitty did u hacked into dbing account?
NWBO
LovePennyStock LovePennyStock 2 시간 전
The next major resistance is $1.72. If we break that , then I believe the share price will go much much higher to a new range between $4-$9. I'm ready to sell my first portion at $4. If anyone can post a screenshot of the Level2 of QMMM, I'd be really appreciated. Let's rock and roll !!!!!!!!
QMMM
cojoboy cojoboy 2 시간 전
Looks like my 73's look like chit..come on peeps..you attack for good buys..attack me for bad ones..😎😎😎😎😎
IGPK

최근 히스토리

NASDAQ
BCAX
Bicara Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지